Acro Biomedical (ACBM) Interest Coverage Ratio (2018 - 2025)
Acro Biomedical (ACBM) recorded quarterly Interest Coverage Ratio of 42.47 in Q3 2025, down 507.72% quarter-over-quarter from 6.99 in Q2 2025, and down 423.79% on a YoY basis from 13.12 in Q3 2024.
Acro Biomedical (ACBM) Interest Coverage Ratio (2018 - 2025) Analysis & Trends
Acro Biomedical's Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 42.47 for Q3 2025.
- In Q3 2025, Interest Coverage Ratio fell 423.79% year-over-year to 42.47; the TTM figure through Dec 2025 stood at 25.56 (down 1148.85% YoY), while the FY2024 annual figure was 2.05, up 99.65% from the prior year.
- Interest Coverage Ratio was 42.47 for Q3 2025 at Acro Biomedical, down from 6.99 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 8268.62 in Q4 2023 to a low of 18940.44 in Q2 2022.
- Historically, Interest Coverage Ratio has averaged 3678.77 across 5 years, with a median of 42.47 in 2025.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio sank 82455.26% in 2022, then surged 265.42% in 2023.
- A 5-year view of Interest Coverage Ratio shows it stood at 1221.11 in 2021, then slumped by 509.35% to 4998.59 in 2022, then soared by 265.42% to 8268.62 in 2023, then sank by 99.8% to 16.27 in 2024, then slumped by 361.01% to 42.47 in 2025.
- The last three Interest Coverage Ratio figures came in at 42.47 (Q3 2025), 6.99 (Q2 2025), and 6.54 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -42.47 |
| Jun 30, 2025 | -6.99 |
| Mar 31, 2025 | -6.54 |
| Dec 31, 2024 | 16.27 |
| Sep 30, 2024 | -8.11 |
| Jun 30, 2024 | -8.60 |
| Mar 31, 2024 | -10.79 |
| Dec 31, 2023 | 8,268.62 |
| Sep 30, 2023 | -2,011.01 |
| Jun 30, 2023 | -4,049.05 |
| Mar 31, 2023 | -5,080.67 |
| Dec 31, 2022 | -4,998.59 |
| Sep 30, 2022 | -8,037.72 |
| Jun 30, 2022 | -18,940.44 |
| Mar 31, 2022 | -18,797.07 |
| Dec 31, 2021 | 1,221.11 |
| Sep 30, 2021 | -16,801.44 |
| Jun 30, 2021 | -580.34 |
| Mar 31, 2021 | -22.77 |
| Sep 30, 2020 | -45.92 |